VIVAPHARMA
ActiveSummary
VIVAPHARMA has been active since 2019 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €126,780 and a net result of €118,241. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 68% of 4,958 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Articles of association
- Other provisionsOther rules from the articles that fall under none of the themes above.
- 1 more provision in the deed, see the deed of 12-01-2026
Read from the deeds: 1 provision, deed of 12-01-2026